Facilitated Allergen Binding (FAB) Is a Meaningful Immunological Biomarker for Monitoring Immediate Clinical Efficacy in Short-Term Peptide Allergen Immunotherapy

Methods Data was collected from a DBPC dose-finding study in 198 patients who received placebo or a peptidase-hydrolysate of grass-pollen peptides at 5 visits over 4 weeks at cumulative doses of up to 370μg (EudraCT-No:2013-005445-37).

Bibliographische Detailangaben

Veröffentlicht in:	Journal of allergy and clinical immunology 2016-02, Vol.137 (2), p.AB403-AB403
Hauptverfasser:	Allekotte, Silke, Dr, Shamji, Mohamed H., Dr, Zadoyan, Gregor V., Dr, Kasche, Elena M., Ms, Shah-Hosseini, Kija, Dr, Astvatsatourov, Anatoli, Dr, Pirotton, Sabine, Dr, Caplanusi, Adrian, Dr, Durham, Stephen R., Prof, Mosges, Ralph, Prof
Format:	Artikel
Sprache:	eng
Schlagworte:	Allergies Allergy and Immunology Immunology Immunotherapy Peptides Short term
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!